Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Immune Pharmaceuticals Inc (IMNP)

0.8251 -0.009 (-1.09%)

12-11 15:59

Open:

0.8389

Pre. Close:

0.8342

High:

0.8389

Low:

0.825

Volume:

196,447

Market Cap:

15M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

0.87 - 0.89

0.89 - 0.92

Low:

0.77 - 0.79

0.79 - 0.81

Close:

0.81 - 0.84

0.84 - 0.88

Technical analysis  (as of: 2017-12-11 4:48:27 PM)

Overall:

      

Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.

Target:

Six months: 1.11     One year: 1.23

Support:

Support1: 0.80    Support2: 0.67

Resistance:

Resistance1: 0.95    Resistance2: 1.05

Pivot:

0.85

Moving Averages:

MA(5): 0.83     MA(20): 0.85

MA(100): 1.25     MA(250): 1.29

MACD:

MACD(12,26): -0.04     Signal(12,26,9): -0.05

%K %D:

%K(14,3): 7.65     %D(3): 6.72

RSI:

RSI(14): 39.54

52-Week:

High: 5.02  Low: 0.12  Change(%): 312.6

Average Vol(K):

3-Month: 74042  10-Days 40692

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
IMNP has closed above bottom band by 30.3%. Bollinger Bands are 79.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to IMNP's normal range. The bands have been in this narrow range for 22 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Tue, 03 Oct 2017 15:56:09 GMT
Reviewing Marinus Pharmaceuticals (MRNS) and Immune Pharmaceuticals (NASDAQ:IMNP)

Thu, 19 Oct 2017 13:01:18 GMT
Immune Pharmaceuticals Inc. Announces Pricing of $18000000 Public Offering of ...

Thu, 29 Jun 2017 14:48:45 GMT
BRIEF-Immune Pharmaceuticals' Oncology subsidiary, Cytovia Inc. Provides ...

Fri, 04 Aug 2017 14:17:12 GMT
Immune Pharmaceuticals, Inc. Issues Letter to Shareholders

Wed, 27 Sep 2017 12:22:02 GMT
Immune Pharmaceuticals shares surge 75% on positive mid-stage clinical trial ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Pharmaceuticals

Shares Out. (M)

17.55

Shares Float (M)

16.27

% Held by Insiders

4.98

% Held by Institutions

2.01

Shares Short (K)

1530

Shares Short Prior Month (K)

1390

Stock Financials

EPS

-2.806

EPS Est. Current Year

-0.620

EPS Est. Next Year

0.170

EPS Est. Next Quarter

Forward EPS

0.170

Book Value (p.s.)

0.040

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-27.2

Return on Equity (ttm)

-430.8

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.637

Qtrly Earnings Growth

Operating Cash Flow (M)

-8.19

Levered Free Cash Flow (M)

-3.86

atoplab.com

Valuation

P/E

-0.29

P/E Growth Ratio

-0.01

P/BV

20.63

P/S

P/CF

-1.77

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2017-04-13

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.